[HTML][HTML] All about (NK cell-mediated) death in two acts and an unexpected encore: initiation, execution and activation of adaptive immunity

A Ramírez-Labrada, C Pesini, L Santiago… - Frontiers in …, 2022 - frontiersin.org
NK cells are key mediators of immune cell-mediated cytotoxicity toward infected and
transformed cells, being one of the main executors of cell death in the immune system. NK …

Cancer immunoediting: from immune surveillance to immune escape

R Kim - Cancer Immunotherapy, 2007 - Elsevier
Publisher Summary This chapter provides an overview of how diverse mechanisms of
immunoediting preserve positive features of the immune stromal environment that facilitate …

Natural killer (NK) cell–mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells

L Zamai, M Ahmad, IM Bennett, L Azzoni… - The Journal of …, 1998 - rupress.org
Mature natural killer (NK) cells use Ca2+-dependent granule exocytosis and release of
cytotoxic proteins, Fas ligand (FasL), and membrane-bound or secreted cytokines (tumor …

Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92

G Maki, HG Klingemann, JA Martinson… - … of hematotherapy & …, 2001 - liebertpub.com
NK-92, a highly cytotoxic, interleukin-2 (IL-2)-dependent human natural killer (NK) cell line,
has been of interest for basic and translational research. We report on a comprehensive …

Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity

JP Aubry, A Blaecke… - … : The Journal of the …, 1999 - Wiley Online Library
Background: Current cytotoxic assays, including Cr release and fluorescent assays, do not
directly measure the proportion of target cells which are killed by apoptosis. Cell‐mediated …

Trial watch: intratumoral immunotherapy

J Humeau, J Le Naour, L Galluzzi, G Kroemer… - …, 2021 - Taylor & Francis
While chemotherapy and radiotherapy remain the first-line approaches for the management
of most unresectable tumors, immunotherapy has emerged in the past two decades as a …

KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-γ production

A Kikuchi-Maki, S Yusa, TL Catina… - The Journal of …, 2003 - journals.aai.org
Killer cell Ig-like receptor (KIR) 2DL4 (2DL4, CD158d) was previously described as the only
KIR expressed by every human NK cell. It is also structurally atypical among KIRs because it …

[HTML][HTML] Curcumin and tumor immune-editing: resurrecting the immune system

S Bose, AK Panda, S Mukherjee, G Sa - Cell division, 2015 - Springer
Curcumin has long been known to posses medicinal properties and recent scientific studies
have shown its efficacy in treating cancer. Curcumin is now considered to be a promising …

[HTML][HTML] Bispecific T cell engager (BiTE®) antibody constructs can mediate bystander tumor cell killing

SL Ross, M Sherman, PL McElroy, JA Lofgren… - PloS one, 2017 - journals.plos.org
For targets that are homogenously expressed, such as CD19 on cells of the B lymphocyte
lineage, immunotherapies can be highly effective. Targeting CD19 with blinatumomab, a …

Targeting of human dendritic cells by autologous NK cells

JL Wilson, LC Heffler, J Charo, A Scheynius… - The Journal of …, 1999 - journals.aai.org
NK cells have the capacity to spontaneously kill tumor cell lines, in particular cell lines of
hemopoietic origin. In contrast, they do not generally kill nontransformed autologous cells …